Garrison Michael David Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
6
Insider Sells Sum
$1.92M

Insider Activity of Garrison Michael David

According to the SEC Form 4 filings, Garrison Michael David, being in a position of

  1. EVP & Pres Med.Essntl&BioPharm at Becton, Dickinson and Company,
    оver the last 12 months, has bought 0 shares, and sold 4439 shares for $784,162,
    over all time since 2023-08-08, has bought 0 shares, and sold 13792 shares for $2.91M.

Biography of Garrison Michael David

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$784,1624100

Comparison of Insiders on Amount of Buys and Sells

2026-06-24SaleBecton, Dickinson and Company
BDX
EVP & Pres Med.Essntl&BioPharm
1,100
0.0003%
$145.66$160,226+23.32%
2026-06-10SaleBecton, Dickinson and Company
BDX
EVP & Pres Med.Essntl&BioPharm
1,100
0.0003%
$151.48$166,628+22.72%
2026-01-15SaleBecton, Dickinson and Company
BDX
EVP & Pres Med.Essntl&BioPharm
1,610
0.0006%
$207.46$334,005-1.11%
2025-12-17SaleBecton, Dickinson and Company
BDX
EVP & Pres Med.Essntl&BioPharm
629
0.0002%
$196.03$123,303+4.34%
2025-07-18SaleBecton, Dickinson and Company
BDX
EVP & President, Medical
1,185
0.0004%
$180.29$213,645+9.01%
2025-04-09SaleBecton, Dickinson and Company
BDX
EVP & President, Medical
479
0.0002%
$197.28$94,497-7.29%
2025-01-17SaleBecton, Dickinson and Company
BDX
EVP & President, Medical
597
0.0002%
$236.51$141,196-17.77%
2024-12-19SaleBecton, Dickinson and Company
BDX
EVP & President, Medical
2,838
0.001%
$223.33$633,811-12.79%
2024-04-30SaleBecton, Dickinson and Company
BDX
EVP & President Medical
1,715
0.0006%
$232.81$399,269-0.12%
2023-12-11SaleBecton, Dickinson and Company
BDX
EVP & President Medical
1,239
0.0004%
$232.46$288,018+1.89%
2023-08-08SaleBecton, Dickinson and Company
BDX
EVP & President Medical
1,300
0.0005%
$277.13$360,269-14.29%
Total: 11
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.